RU2001118849A - Очистка циклопептидных соединений эхинокандина - Google Patents

Очистка циклопептидных соединений эхинокандина Download PDF

Info

Publication number
RU2001118849A
RU2001118849A RU2001118849/04A RU2001118849A RU2001118849A RU 2001118849 A RU2001118849 A RU 2001118849A RU 2001118849/04 A RU2001118849/04 A RU 2001118849/04A RU 2001118849 A RU2001118849 A RU 2001118849A RU 2001118849 A RU2001118849 A RU 2001118849A
Authority
RU
Russia
Prior art keywords
mixture
product
group
iii
acetic acid
Prior art date
Application number
RU2001118849/04A
Other languages
English (en)
Russian (ru)
Inventor
Джон Роберт ДОББИНС (US)
Джон Роберт ДОББИНС
Юджин Пол КРОЭФФ (US)
Юджин Пол КРОЭФФ
Джеффри Томас ВАЙСЕНЗИ (US)
Джеффри Томас ВАЙСЕНЗИ
Original Assignee
Эли Лилли энд Компани (US)
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли энд Компани (US), Эли Лилли Энд Компани filed Critical Эли Лилли энд Компани (US)
Publication of RU2001118849A publication Critical patent/RU2001118849A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RU2001118849/04A 1998-12-09 1999-12-08 Очистка циклопептидных соединений эхинокандина RU2001118849A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11152498P 1998-12-09 1998-12-09
US60/111,524 1998-12-09

Publications (1)

Publication Number Publication Date
RU2001118849A true RU2001118849A (ru) 2003-08-10

Family

ID=22339024

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001118849/04A RU2001118849A (ru) 1998-12-09 1999-12-08 Очистка циклопептидных соединений эхинокандина

Country Status (17)

Country Link
US (1) US6506726B1 (https=)
EP (1) EP1137663B1 (https=)
JP (1) JP2003511345A (https=)
KR (1) KR20010101151A (https=)
CN (1) CN1337968A (https=)
AT (1) ATE338059T1 (https=)
AU (1) AU766091B2 (https=)
BR (1) BR9916101A (https=)
CA (1) CA2353930A1 (https=)
DE (1) DE69933046T2 (https=)
DK (1) DK1137663T3 (https=)
ES (1) ES2272096T3 (https=)
IL (1) IL143563A0 (https=)
PT (1) PT1137663E (https=)
RU (1) RU2001118849A (https=)
WO (1) WO2000034315A2 (https=)
ZA (1) ZA200104621B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2583262C2 (ru) * 2011-04-20 2016-05-10 Кселлия Фармасьютикалз Апс Способ очистки микафунгина
CN106248857A (zh) * 2016-07-15 2016-12-21 广西医科大学 利用薄层层析快速检测植物环肽的方法

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
HK1040062A1 (zh) * 1999-03-03 2002-05-24 Eli Lilly And Company 含有成胶束表面活性剂的棘白菌素药物配方
ATE248187T1 (de) 1999-03-03 2003-09-15 Lilly Co Eli Echinocandin-kohlenhydrate-komplexe
HK1040369A1 (zh) 1999-03-03 2002-06-07 Eli Lilly And Company 制备药物口服ecb配方和组合物的方法
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
JP5112060B2 (ja) * 2004-06-29 2013-01-09 リライアンス ライフ サイエンシーズ プライベイト リミテッド ウイルス安全性生物学的流体の調製のための方法
DE102004060750A1 (de) 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
CN102219832B (zh) 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102336817B (zh) * 2010-07-16 2016-06-15 浙江震元制药有限公司 棘球白素b母核的分离方法
ES2581562T3 (es) 2010-09-29 2016-09-06 Shanghai Techwell Biopharmaceutical Co., Ltd Procedimiento para purificar compuestos lipopeptídicos cíclicos o sales de los mismos
CN102443050B (zh) * 2010-09-30 2014-06-04 上海天伟生物制药有限公司 一种环脂肽化合物或其盐的纯化方法
CN102153616A (zh) * 2010-12-27 2011-08-17 浙江海正药业股份有限公司 一种环己肽类化合物及其盐的分离纯化方法
WO2012119065A2 (en) 2011-03-03 2012-09-07 Seachaid Pharmaceuticals, Inc. Antifungal agents and uses thereof
CN102952178B (zh) * 2011-08-24 2016-04-27 华北制药集团新药研究开发有限责任公司 一种高纯度棘白霉素类化合物的制备方法
SI3677252T1 (sl) 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov
CN103483427A (zh) * 2012-06-09 2014-01-01 浙江海正药业股份有限公司 一种棘白菌素类化合物的纯化方法
CN103910783B (zh) * 2014-04-23 2016-07-06 华北制药集团新药研究开发有限责任公司 一种高纯度棘白霉素b母核的制备方法
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
CN108883152A (zh) 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
MA43825A (fr) 2016-03-16 2021-04-07 Cidara Therapeutics Inc Schémas posologiques pour le traitement d'infections fongiques
JP7779651B2 (ja) 2017-07-12 2025-12-03 ナップ ファーマシューティカル グループ リミテッド 真菌感染症の処置のための組成物及び方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304716A (en) 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
EP0294990A3 (en) 1987-06-10 1990-05-09 Eli Lilly And Company Chromatographic purification process
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IL98349A (en) 1990-06-07 1995-05-26 Lilly Co Eli Diphylase lipopeptide
IL98506A (en) 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
MY136593A (en) 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
EP0881907A4 (en) 1996-02-01 2000-05-10 Lilly Co Eli FUNGICIDES IN THE FORM OF CYCLIC PEPTIDES
US5696084A (en) 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
WO1999006062A1 (en) 1997-08-04 1999-02-11 Eli Lilly And Company Cyclic peptide antifungal agents
CA2255140A1 (en) 1997-12-23 1999-06-23 Eli Lilly And Company Echinocandin binding domain of 1,3-.beta.-glucan synthase
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
ATE287899T1 (de) 1998-08-20 2005-02-15 Lilly Co Eli Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
CA2340647A1 (en) 1998-08-28 2000-03-09 Eli Lilly And Company Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
WO2000024694A1 (en) 1998-10-28 2000-05-04 Eli Lilly And Company Photochemical process for making 1-deoxy-2-keto derivatives
AU767357B2 (en) 1998-12-16 2003-11-06 Eli Lilly And Company Cyclic peptide antifungal agents
AU2189500A (en) 1998-12-16 2000-07-03 Eli Lilly And Company Cyclic peptide antifungal agents having a sugar substituent
HK1040369A1 (zh) 1999-03-03 2002-06-07 Eli Lilly And Company 制备药物口服ecb配方和组合物的方法
ATE248187T1 (de) 1999-03-03 2003-09-15 Lilly Co Eli Echinocandin-kohlenhydrate-komplexe
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
HK1040062A1 (zh) 1999-03-03 2002-05-24 Eli Lilly And Company 含有成胶束表面活性剂的棘白菌素药物配方

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2583262C2 (ru) * 2011-04-20 2016-05-10 Кселлия Фармасьютикалз Апс Способ очистки микафунгина
CN106248857A (zh) * 2016-07-15 2016-12-21 广西医科大学 利用薄层层析快速检测植物环肽的方法

Also Published As

Publication number Publication date
EP1137663B1 (en) 2006-08-30
ES2272096T3 (es) 2007-04-16
IL143563A0 (en) 2002-04-21
KR20010101151A (ko) 2001-11-14
CN1337968A (zh) 2002-02-27
EP1137663A2 (en) 2001-10-04
BR9916101A (pt) 2002-06-04
US6506726B1 (en) 2003-01-14
ZA200104621B (en) 2002-06-06
DE69933046D1 (de) 2006-10-12
PT1137663E (pt) 2006-12-29
CA2353930A1 (en) 2000-06-15
WO2000034315A3 (en) 2000-12-28
WO2000034315A2 (en) 2000-06-15
AU3113200A (en) 2000-06-26
WO2000034315A8 (en) 2000-10-26
ATE338059T1 (de) 2006-09-15
DE69933046T2 (de) 2007-09-13
DK1137663T3 (da) 2007-01-08
JP2003511345A (ja) 2003-03-25
AU766091B2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
RU2001118849A (ru) Очистка циклопептидных соединений эхинокандина
JP2003511345A5 (https=)
CA1306988C (en) Separation medium
KR960002868B1 (ko) 글리코펩티드 항생물질의 회수 방법
Yang et al. Immobilized iminodiacetic acid (IDA)‐type Cu2+‐chelating membrane affinity chromatography for purification of bovine liver catalase
CN1313866A (zh) 色谱纯化胰岛素的方法
Yu et al. Zwitterionic stationary phases in HPLC
KR20030059171A (ko) 아미노산 유도체의 광학 이성체의 분리 방법
US5071560A (en) Process for purifying phenylalanine
JPH10295396A (ja) モエノマイシンaの製造法
CN114225919B (zh) 一种内毒素吸附剂及其制备方法与应用
CN1717484A (zh) 反义寡核苷酸的分离
CN118546185A (zh) 一种甘油葡糖苷的分离纯化方法
US5180670A (en) Method for purification of mitomycin C
JPS60169427A (ja) タンパク質の分離方法
JPH013129A (ja) 光学異性体用分離剤
US3000873A (en) Antibiotic recovery process
McCune Synthesis and evaluation of N-3, 5-dinitrobenzoyl-beta-amino acid derived chiral stationary phases
KR100385152B1 (ko) 카프레오마이신의 정제방법
JPS60181055A (ja) フエニルアラニンと桂皮酸の分離方法
JP4070904B2 (ja) イオン化する化合物用の分離剤およびその製造方法
Grinberg et al. Chiral Separations
RU2049792C1 (ru) Способ выделения стероидных веществ из культуральной жидкости
JP2001278892A (ja) エリスロマイシンfの分離、除去方法
Mierzwa et al. HPLC Separation of Two Novel Oiketopiperazine Isomers on Polyvinyl Alcohol Functionalized Silica Gel

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20050317